CLEARSIDE BIOMEDICAL INC's ticker is and the CUSIP is 185063904. A total of 3 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,574 | -22.3% | 27,100 | 0.0% | 0.00% | – |
| Q2 2023 | $30,352 | -3.7% | 27,100 | -10.6% | 0.00% | – |
| Q1 2023 | $31,512 | -69.4% | 30,300 | -67.0% | 0.00% | – |
| Q4 2022 | $102,816 | +0.8% | 91,800 | +1.8% | 0.00% | – |
| Q3 2022 | $102,000 | -35.8% | 90,200 | -16.6% | 0.00% | – |
| Q2 2022 | $159,000 | -33.8% | 108,200 | +3.1% | 0.00% | – |
| Q1 2022 | $240,000 | +96.7% | 104,900 | +137.3% | 0.00% | – |
| Q4 2021 | $122,000 | -77.6% | 44,200 | -51.2% | 0.00% | -100.0% |
| Q3 2021 | $544,000 | -41.2% | 90,600 | -52.3% | 0.00% | 0.0% |
| Q2 2021 | $925,000 | +450.6% | 189,900 | +179.7% | 0.00% | – |
| Q1 2021 | $168,000 | +4100.0% | 67,900 | +4143.8% | 0.00% | – |
| Q4 2020 | $4,000 | -90.0% | 1,600 | -93.8% | 0.00% | – |
| Q3 2020 | $40,000 | +263.6% | 25,700 | +328.3% | 0.00% | – |
| Q2 2020 | $11,000 | -88.7% | 6,000 | -89.4% | 0.00% | -100.0% |
| Q1 2020 | $97,000 | -52.2% | 56,800 | -18.7% | 0.00% | 0.0% |
| Q4 2019 | $203,000 | +420.5% | 69,900 | +74.3% | 0.00% | – |
| Q2 2019 | $39,000 | -52.4% | 40,100 | -32.7% | 0.00% | -100.0% |
| Q1 2019 | $82,000 | +811.1% | 59,600 | +618.1% | 0.00% | – |
| Q4 2018 | $9,000 | -25.0% | 8,300 | +336.8% | 0.00% | – |
| Q3 2018 | $12,000 | -90.6% | 1,900 | -84.0% | 0.00% | -100.0% |
| Q2 2018 | $127,000 | -63.4% | 11,900 | -63.2% | 0.00% | -66.7% |
| Q1 2018 | $347,000 | – | 32,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,600 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 19 | $0 | 0.00% |